Young people could be spared from going blind by a new genetic risk tool that could also help diagnose multiple sclerosis (MS) earlier, to start effective treatments.
How Medtronic, Zimmer Biomet and Smith & Nephew are thinking about acquisitions, spinoffs
Rising interest rates and market volatility have put a damper on mergers and acquisitions. Large purchases have been few and far between, with most medical